Full-Time

Project Engineer 2

Posted on 1/24/2026

PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

Compensation Overview

$86.9k - $103.2k/yr

+ Bonus

Rockford, IL, USA

In Person

Category
Mechanical Engineering (2)
,
Required Skills
Six Sigma
FDA Regulations
Risk Management
Data Analysis
Requirements
  • Bachelor’s degree in Mechanical, Biomedical, Chemical, or related Engineering discipline.
  • 5–10 years of engineering or project management experience in a regulated manufacturing environment.
  • Strong understanding of Design Controls (CFR 820.30 / ISO 13485) and Risk Management (ISO 14971).
  • High proficiency in data analysis, problem-solving, and process optimization.
  • Strong verbal and written communication skills.
  • College-level mathematical skills.
  • Full professional proficiency in English.
  • Advanced reasoning and decision-making abilities.
Responsibilities
  • Lead the specification, procurement, and commissioning of pharmaceutical manufacturing and packaging equipment.
  • Author technical documentation, including User Requirement Specifications (URS), Factory Acceptance Testing (FAT), and Site Acceptance Testing (SAT).
  • Manage Capital Equipment Requests (CERs), including cost justification, budgeting, and timeline oversight.
  • Oversee the equipment acquisition and installation process in accordance with SOPs.
  • Use tools such as Design of Experiments (DOE) to optimize performance and validate results.
  • Serve as engineering subject matter expert across multiple packaging value streams.
  • Lead product launches, ensuring equipment readiness and process capability.
  • Identify and resolve process inefficiencies, focusing on Overall Equipment Effectiveness (OEE), defect reduction, and waste elimination.
  • Lead root cause investigations, Corrective and Preventive Actions (CAPAs), and continuous improvement using Lean and Six Sigma methodologies.
  • Act as the technical liaison with clients during audits, meetings, and new product discussions.
  • Collaborate with Sales and Business Development teams to define packaging and equipment needs.
  • Provide engineering training and develop SOPs, production line layouts, and visual diagrams.
  • Support Validation during OQ and PQ for new business.
  • Conduct and document engineering investigations and manage change control processes.
  • Ensure strict adherence to all cGMP and FDA regulations and internal quality systems.
Desired Qualifications
  • Experience with pharmaceutical or medical device packaging equipment (e.g., blister, pouch, bottling, cartoning).
  • Familiarity with cGMPs and pharmaceutical manufacturing environments.
  • Skilled in Microsoft Office Suite, Microsoft Project, Visio, and AutoCAD.
  • Proven experience leading cross-functional project teams and working with clients.
  • Lean Six Sigma Green Belt or Black Belt certification a plus.

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • GLP-1 surge drives demand for PCI's prefilled syringes and autoinjectors.
  • Oncology-CNS pipelines favor PCI's patient-centric drug-device combinations.
  • Bain Capital's $10B valuation fuels $1B capacity expansions through 2028.

What critics are saying

  • San Diego isolator line delays to H1 2028 cede contracts to Lonza.
  • Novo Nordisk's Catalent acquisition slashes external CDMO fill-finish availability.
  • PE backers force divestitures if biotech funding dries post-2025.

What makes PCI Pharma Services unique

  • PCI integrates sterile fill-finish with drug-device assembly for end-to-end injectables.
  • Ajinomoto Althea acquisition adds rare US high-potent ADC sterile filling expertise.
  • AVI systems inspect 75 million vials annually, scaling quality without bottlenecks.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.

INACTIVE